Albendazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200 mg
Reference Brands: Albenza(US & EU)
Category:
Medical Aid
Albendazole inhibits parasite beta-tubulin, disrupting microtubule formation essential for energy production and cell division. It is effective against various helminths, including roundworms and tapeworms. Benefits include rapid parasitic eradication, broad-spectrum activity, oral convenience, and a good safety profile when used as prescribed, making it essential in antiparasitic therapy.
Albendazole tablets is available in Tablets
and strengths such as 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Albendazole tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Albendazole tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Albendazole tablets are approved in the EU and US for treating parasitic infections such as neurocysticercosis and echinococcosis. In the EU, brands like Albenza (by GSK) are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval is based on comprehensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers and compliance, visit PharmaTradz. We facilitate seamless market access for albendazole, ensuring adherence to European and US standards for safe, effective antiparasitic therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing